Five major pharmaceutical companies currently produce FDA-approved GLP-1 medications for weight loss: Novo Nordisk (semaglutide, tirzepatide), Eli Lilly (tirzepatide, retatrutide), Viking Therapeutics, Structure Therapeutics, and Amgen
GLP-1 is reported to exert important functions in the management of type 2 diabetes (T2D) and obesity, including regulation of glucose homeostasis, gastric motility and food intake
doi: 10.7861/clinmedicine.15-2-145 75 BrasitusTA
Use the Peptide Interaction Checker before combining with other compounds and the Peptide Unit Converter for weight-based dose calculations
This approach ensures you receive advice that fits your specific needs
Receive Your Prescription and Medication: We handle all insurance verification and prior authorization, delivering your medication to your doorstep